Rodrigo Escobar - Concepedia

Author

Rodrigo Escobar

Also Known As

Eliobas Oliveira Nunes, Escobar R, R Escobar, R. Escobar, R. R. Escobar, RODRIGO ESCOBAR, Rodrigo Escobar, Rodrigo R. Escobar, Rodrigo Renda Escobar, Rodrigo Renda de Escobar

104

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (Spain)Eli Lilly (United States)Vall d'Hebron Hospital Universitari Clinical Solutions Eli Lilly (Japan)

About

Rodrigo Escobar is an author at Eli Lilly (Spain) specializing in medicine, psychopathology, and psychiatry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	355
2	Social Sciences	5	5	318
3	Health Sciences	1	1	16
4	Anesthesia	1	1	21
5	Behavioral Health	1	1	16

Rodrigo Escobar

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Worse Quality of Life for Children With Newly Diagnosed Attention-Deficit/Hyperactivity Disorder, Compared With Asthmatic and Healthy Children Rodrigo Escobar, César A. Soutullo, Amaia Hervás, PEDIATRICS	2005	187
A Randomized Double-Blind Study of Atomoxetine Versus Placebo for Attention-Deficit/Hyperactivity Disorder Symptoms in Children With Autism Spectrum Disorder Myriam Harfterkamp, Gigi van de Loo-Neus, Ruud B. Minderaa, Journal of the American Academy of Child & Adolescent Psychiatry AdhdPsychiatryAtomoxetine Versus PlaceboPediatricsNeuropharmacology	2012	165
Validation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency room Alonso Montoya, Amparo Valladares, Luís Lizán, Health and Quality of Life Outcomes	2011	139
Risk factors for mediastinitis after coronary artery bypass grafting surgery Michel Pompeu Sá, Evelyn Figueira Soares, Cecília Andrade Santos, Brazilian Journal of Cardiovascular Surgery	2011	64
Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder Alonso Montoya, Amaia Hervás, Esther Cardo, Current Medical Research and Opinion	2009	62
Clinical and cerebral blood flow changes in catatonic patients treated with ECT Rodrigo Escobar, Alejandro Rios, Iván D. Montoya, Journal of Psychosomatic Research SleepElectrophysiological EvaluationNeurophysiologyCatatonic PatientsElectroconvulsive Therapy	2000	60
Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study Grazia Dell’Agnello, Dino Maschietto, Carmela Bravaccio, European Neuropsychopharmacology AdhdPsychiatryMedicinePsychotropic MedicationPediatrics	2009	54
Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder Rodrigo Escobar, Alonso Montoya, Pepa Polavieja, Journal of Child and Adolescent Psychopharmacology	2009	48
Maintenance of response after open-label treatment with atomoxetine hydrochloride in international European and non-European adult outpatients with attention-deficit/hyperactivity disorder: a placebo-controlled, randomised withdrawal study Himanshu P. Upadhyaya, Josep Antoni Ramos‐Quiroga, Lenard A. Adler, The European Journal of Psychiatry	2013	30
Executive Function in Adults With Attention-Deficit/Hyperactivity Disorder During Treatment With Atomoxetine in a Randomized, Placebo-Controlled, Withdrawal Study Lenard A. Adler, Yoko Tanaka, David W. Williams, Journal of Clinical Psychopharmacology Psychotropic MedicationPsychopharmacologyAttentionSocial SciencesPsychology	2014	28

Page 1